Sanofi traded at 84.28 this Friday February 3rd, decreasing 2.49 or 2.87 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 8.66 percent. Over the last 12 months, its price fell by 6.66 percent. Looking ahead, we forecast Sanofi to be priced at 86.35 by the end of this quarter and at 77.26 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
85.20
Daily Change
-1.81%
Yearly
-5.64%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 146.16 1.32 0.91% 3.92%
Aena 139.65 -1.60 -1.13% -2.82%
Alcon AG 69.50 -0.86 -1.22% -1.78%
Almirall SA 9.32 0.15 1.58% -16.79%
Amgen 244.07 -2.46 -1.00% 9.89%
Amarin 1.93 -0.02 -1.03% -46.98%
Artemis Alpha 338.00 -12.00 -3.43% -14.43%
AstraZeneca 10,538.00 288.00 2.81% 27.24%
Bayer 56.86 0.06 0.11% 8.06%
Biogen 290.44 2.92 1.02% 31.11%
BMW 97.40 -0.39 -0.40% 8.63%
Bristol-Myers Squibb 73.33 0.56 0.77% 12.83%
Mercedes-Benz Group AG 71.94 -0.26 -0.36% 6.06%
Vinci 104.26 -0.78 -0.74% 6.18%
Essilor 176.45 5.70 3.34% 2.63%
Fresenius Medical Care 35.47 -0.29 -0.81% -41.62%
Fresenius 27.12 -0.11 -0.40% -26.68%
Genmab 2,630.00 26.00 1.00% 16.84%
Gilead Sciences 84.86 3.47 4.26% 29.78%
Galapagos 40.24 0.21 0.52% -29.82%
GRIFOLS 13.51 0.24 1.81% -10.86%
GlaxoSmithKline 1,442.80 15.40 1.08% -11.76%
Hikma Pharmaceutical 1,732.00 20.00 1.17% -13.62%
J&J 164.68 -0.86 -0.52% -4.68%
Eli Lilly 334.72 4.02 1.22% 36.73%
Lonza Group 543.00 -3.60 -0.66% -12.90%
Merck 184.35 0.30 0.16% -3.56%
Merck & Co 102.96 -0.50 -0.48% 31.06%
Novartis 79.84 1.58 2.02% 0%
Orion 49.16 0.58 1.19% 39.38%
Pfizer 44.15 -0.19 -0.43% -17.29%
Philips 16.59 -0.11 -0.64% -42.61%
Recordati 39.82 -0.16 -0.40% -15.90%
Regeneron Pharmaceuticals 766.00 14.80 1.97% 22.96%
Roche Holding 281.40 7.55 2.76% -18.49%
Sanofi 85.20 -1.57 -1.81% -5.64%
SAP 111.30 -1.28 -1.14% 1.94%
UCB 74.34 1.12 1.53% -15.81%
Volkswagen 131.78 -1.52 -1.14% -25.18%

Indexes Price Day Year
EU50 4235 -6.30 -0.15% 3.63%
FR40 7184 18.14 0.25% 3.35%
EU100 1344 0.01 0% 2.87%

Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.